Fig. 2.
(A) the CD19+ lymphocyte subpopulations induced by the immunogenic factors after the 24-h treatment: CD38-CD24+ (memory cells), CD38+CD24+ (transitional cells), CD38+CD24-(plasmablasts); (B) the subsets of the memory B cells (CD19+ CD24+CD38-): CS, NCS, and NAÏVE; multiple unpaired t-tests: significant differences between the means of mock vs. the marked treatments (P ≤ 0.05). Data are shown as means ± SD of four independent experiments